Representative Tim Moore (R-North Carolina) recently sold shares of Colgate-Palmolive Company (NYSE:CL). In a filing disclosed on October 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Colgate-Palmolive stock on September 10th. The trade occurred in the Representative’s “TRADEWINDS” account.
Representative Tim Moore also recently made the following trade(s):
- Sold $50,001 – $100,000 in shares of Hyster-Yale (NYSE:HY) on 9/19/2025.
- Purchased $50,001 – $100,000 in shares of Hyster-Yale (NYSE:HY) on 9/11/2025.
- Purchased $15,001 – $50,000 in shares of Coinbase Global (NASDAQ:COIN) on 9/11/2025.
- Sold $1,001 – $15,000 in shares of Procter & Gamble (NYSE:PG) on 9/10/2025.
- Sold $100,001 – $250,000 in shares of Centene (NYSE:CNC) on 8/18/2025.
- Sold $50,001 – $100,000 in shares of UnitedHealth Group (NYSE:UNH) on 8/15/2025.
- Sold $100,001 – $250,000 in shares of Intel (NASDAQ:INTC) on 8/13/2025.
- Sold $50,001 – $100,000 in shares of Hyster-Yale (NYSE:HY) on 8/13/2025.
- Purchased $15,001 – $50,000 in shares of Hyster-Yale (NYSE:HY) on 8/12/2025.
- Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 8/11/2025.
Colgate-Palmolive Stock Performance
CL opened at $78.43 on Wednesday. The firm has a market capitalization of $63.39 billion, a PE ratio of 22.03, a PEG ratio of 4.24 and a beta of 0.34. Colgate-Palmolive Company has a twelve month low of $76.68 and a twelve month high of $102.61. The firm’s 50-day moving average price is $82.34 and its 200 day moving average price is $87.67. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. Colgate-Palmolive’s payout ratio is presently 58.43%.
Analyst Upgrades and Downgrades
CL has been the topic of several recent analyst reports. JPMorgan Chase & Co. decreased their target price on shares of Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. The Goldman Sachs Group decreased their target price on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $86.00 target price on shares of Colgate-Palmolive in a report on Friday. Finally, Citigroup decreased their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, August 4th. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $92.21.
Institutional Investors Weigh In On Colgate-Palmolive
A number of institutional investors and hedge funds have recently made changes to their positions in CL. Personal CFO Solutions LLC purchased a new stake in Colgate-Palmolive during the 1st quarter worth approximately $285,000. Vision Capital Management Inc. acquired a new stake in Colgate-Palmolive during the 1st quarter worth approximately $322,000. Autumn Glory Partners LLC lifted its holdings in Colgate-Palmolive by 67.4% during the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company’s stock worth $851,000 after buying an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. acquired a new stake in Colgate-Palmolive during the 1st quarter worth approximately $2,166,000. Finally, Penserra Capital Management LLC lifted its holdings in Colgate-Palmolive by 398.6% during the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock worth $997,000 after buying an additional 8,515 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.
About Representative Moore
Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina’s 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Moore (Republican Party) ran for election to the U.S. House to represent North Carolina’s 14th Congressional District. He won in the general election on November 5, 2024.
Moore served as speaker of the House from 2015 to 2025.
Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Why is the Ex-Dividend Date Significant to Investors?
- After Gold Blast Soars Past $4,000, BofA Eyes $5,000 in 2026
- What Are Dividend Challengers?
- Buyback Boom: 3 Companies Betting Big on Themselves
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Analysts Flock to Upgrade DELL After Big AI-Server Guidance Boost
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.